Institutions / Lion Point Capital, LP
Lion Point Capital, LP
CIK 1643354 · Institution · as of Dec 31, 2025
Portfolio value
$19.32M
Positions
39
As of
Dec 31, 2025
Top holdings
Dec 31, 2025View all 39 →
| Company | Value | % of portfolio |
|---|---|---|
| Milestone Pharmaceuticals Inc. | $1.53M | 7.9% |
| Praxis Precision Medicines, Inc. | $1.31M | 6.8% |
| MoonLake ImmunotherapeuticsMLTX | $889.6K | 4.6% |
| Fennec Pharmaceuticals Inc. | $865.7K | 4.5% |
| Jasper Therapeutics IncJSPR | $851.0K | 4.4% |
| Benitec Biopharma Inc.BNTC | $835.1K | 4.3% |
| Royalty Pharma PLC | $826.9K | 4.3% |
| Geron Corp | $763.0K | 3.9% |
| Syndax Pharmaceuticals Inc | $756.4K | 3.9% |
| Ardelyx, Inc. | $750.0K | 3.9% |
| Cue Biopharma Inc | $672.8K | 3.5% |
| Disc Medicine, Inc.IRON | $643.2K | 3.3% |
| Sarepta Therapeutics, Inc. | $613.3K | 3.2% |
| Biohaven Ltd. | $583.7K | 3.0% |
| Humacyte Inc | $480.3K | 2.5% |
| Kura Oncology, Inc. | $477.9K | 2.5% |
| Seres Therapeutics, Inc.MCRB | $469.8K | 2.4% |
| COMPASS Pathways plcCMPS | $400.2K | 2.1% |
| Day One Biopharmaceuticals, Inc. | $391.4K | 2.0% |
| REGENXBIO Inc. | $383.0K | 2.0% |
| BridgeBio Pharma, Inc. | $382.4K | 2.0% |
| Mineralys Therapeutics IncMLYS | $381.0K | 2.0% |
| Ventyx Biosciences, Inc. | $374.7K | 1.9% |
| Lantheus Holdings, Inc. | $366.0K | 1.9% |
| Dyne Therapeutics, Inc. | $352.1K | 1.8% |
Activity
Dec 31, 2025
InsidersInstitutions
This fund's 13F position changes — what it's buying and selling.No quarter-over-quarter changes yet — position changes appear once we've ingested two consecutive 13F filings for this manager. We currently hold 1 quarter of holdings.